-+ 0.00%
-+ 0.00%
-+ 0.00%

Assessing Marqeta (MQ) Valuation After Q1 Beat And Optimistic Q2 Growth Guidance

Simply Wall St·05/19/2026 00:47:17
Listen to the news

Fresh guidance and earnings reset the conversation around Marqeta stock

Marqeta (MQ) has moved back into focus after first quarter results topped Wall Street expectations, coupled with company guidance that points to continued revenue and gross profit growth in the second quarter.

See our latest analysis for Marqeta.

Despite the upbeat Q1 earnings and Q2 guidance, Marqeta’s 1-day share price return of 3.41% to US$3.94 only partly offsets a weaker trend. The 30-day share price return is down 10.25% and the 1-year total shareholder return is down 24.81%, suggesting recent optimism is emerging against a softer longer term record.

If you are assessing payment and fintech ideas off the back of Marqeta’s update, it can be useful to see what else is moving among AI linked financial technology stocks by checking 33 AI small caps.

With Marqeta’s Q1 beat, fresh guidance, and a share price still down over the past year, the real question is whether the stock is undervalued today or if the market is already fully pricing in its future growth potential.

Most Popular Narrative: 24.1% Undervalued

The most followed narrative values Marqeta at $5.19 per share, which sits above the last close at $3.94, and frames the current debate around its earnings power.

The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi-market expansion for clients. This could create new revenue streams, increase take rates, and support earnings scalability.

Read the complete narrative.

Want to see what underpins that valuation gap? The narrative focuses on expectations for faster earnings growth, richer margins, and a future profit multiple that assumes real staying power.

Result: Fair Value of $5.19 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on risks such as Marqeta’s heavy reliance on a few large customers and rising competition that could pressure pricing and future profitability assumptions.

Find out about the key risks to this Marqeta narrative.

Another angle on valuation

That $5.19 fair value from the narrative contrasts with how the market is pricing Marqeta on sales today. The stock trades on a P/S ratio of 2.6x, compared with 2.1x for the US Diversified Financial industry, a peer average of 1.1x, and a fair ratio of 2.4x that the market could move towards. That premium suggests less margin for error if growth or margins fall short, so how comfortable are you paying above both peers and the fair ratio for this story?

For a closer look at how the market’s current multiple compares with those peer and industry benchmarks, check the See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:MQ P/S Ratio as at May 2026
NasdaqGS:MQ P/S Ratio as at May 2026

Next Steps

With mixed signals on valuation and sentiment, you should quickly weigh both the upside and the risks and shape your own view using the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

Do not stop your research with a single stock. Broader, thoughtfully chosen ideas can help you build a stronger portfolio and spot opportunities others overlook.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.